GC WellBeing Corporation

234690 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩9,500.00
-1.25%
Delayed · cached 15 min

Fair value analysis

234690
GC WellBeing Corporation
PharmaceuticalsPharmaceuticals
₩9,500.00
Close used for this calculation
₩6,950.81Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
44/100
Profitability6/25
Returns10/25
Balance Sheet12/25
Efficiency16/25
Growth3/25
Average
Quality radar
44Prof.6/25Ret.10/25Eff.16/25B.Sht12/25Growth3/25

Consensus fair value

₩6,950.81
Above FV
▼ -26.8% against the close used
Model range ₩1,816.88 – ₩11,280.00
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,816.88Fair value₩6,950.81Bull₩11,280.00
FairClose
52-week traded range
52W low ₩7,250.0052W high ₩15,100.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

GC WellBeing Corporation closed at ₩9,500.00, 36.7% above the consensus fair value of ₩6,950.81 drawn from 8 valuation models.

Financial DNA score 44/100 — Average. P/E of 16.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩2,148.62
-77.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₩8,964.93
-5.6%
√(22.5 × EPS × BVPS)
EPS=564, BVPS=6333.33 · outside Graham range (P/E 16.8, P/B 1.5) — asset-light, treat as a rough floor
P/E Fair Value
₩11,280.00
+18.7%
EPS × 20x (sector P/E)
EPS=564, Sector P/E=20x
EV/EBITDA
₩8,961.09
-5.7%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=20.98B
Dividend Discount (DDM)
₩1,816.88
-80.9%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=142.5, r=10%, g=2%
Book Value (P/B)
₩5,320.00
-44.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=6333.33, ROE=8.9%, g=3%, r=10%
Reverse DCF
₩9,500.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 4.8% | Historical: 0%
Margin of Safety
₩5,598.39
-41.1%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=7464.52, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.